1. GPCR/G Protein Neuronal Signaling Immunology/Inflammation
  2. Histamine Receptor
  3. SCH 79687

SCH 79687 is an orally active histamine H3 receptor antagonist, with a Ki of 1.9 nM in rats and 13 nM in guinea pigs. SCH 79687 acts as a competitive antagonist against (R)-α-methylhistamine. SCH 79687 attenuates the inhibitory effect of (R)-α-methylhistamine-induced sympathetic hypertensive responses in guinea pigs. When used in combination with H1 antagonists, SCH 79687 inhibits Compound 48/80 (HY-115768)-induced nasal congestion in cats. SCH 79687 can be used for the research of allergic rhinitis.

For research use only. We do not sell to patients.

SCH 79687

SCH 79687 Chemical Structure

CAS No. : 224585-45-9

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Histamine Receptor Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SCH 79687 is an orally active histamine H3 receptor antagonist, with a Ki of 1.9 nM in rats and 13 nM in guinea pigs. SCH 79687 acts as a competitive antagonist against (R)-α-methylhistamine. SCH 79687 attenuates the inhibitory effect of (R)-α-methylhistamine-induced sympathetic hypertensive responses in guinea pigs. When used in combination with H1 antagonists, SCH 79687 inhibits Compound 48/80 (HY-115768)-induced nasal congestion in cats. SCH 79687 can be used for the research of allergic rhinitis[1].

In Vitro

SCH 79687 (1.9-13 nM; 30 min) binds to rat and guinea pig histamine H3 receptors with high affinity (Ki = 1.9 nM and 13 nM), and exhibits extremely weak binding affinity to H1, H2, α2A-adrenergic receptors and imidazoline I2 receptors[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Parmacokinetics
Species Dose Route AUC T1/2 Cmax Tmax
Rat[1] 10 mg/kg p.o. 18.1 μg·h/mL / 1.5 μg/mL 4.5 h
Monkey[1] 3 mg/kg p.o. 12.6 μg·h/mL / 1.7 μg/mL 4.4 h
Monkey[1] 3 mg/kg i.v. 24.1 μg·h/mL 2.5 h / /
In Vivo

SCH 79687 (0.03-3 mg/kg; intravenous injection; single administration) dose-dependently attenuates the inhibitory effect of (R)-α-methylhistamine on sympathetic hypertensive responses in guinea pigs, with an intravenous ED50 of 0.28 mg/kg[1].
SCH 79687 (3-10 mg/kg; intravenous injection, oral administration; single dose) exerts significant decongestant effects via both intravenous (3 mg/kg) and oral (10 mg/kg) routes in a feline model of nasal congestion induced by Compound 48/80 (HY-115768), without increasing blood pressure, when used in combination with Loratadine (HY-17043)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Hartley (male, anesthetized)[1]
Dosage: 0.03 mg/kg; 0.3 mg/kg; 3.0 mg/kg
Administration: i.v.; single dose; 5 min prior to (R)-α-methylhistamine
Result: Produced a dose-dependent attenuation of (R)-α-methylhistamine-induced inhibition of sympathetic hypertensive responses, with an ED50 of 0.28 mg/kg i.v.
Inhibited the (R)-α-methylhistamine response by ~10% at 0.03 mg/kg i.v.
Inhibited the (R)-α-methylhistamine response by ~65% at 0.3 mg/kg i.v.
Inhibited the (R)-α-methylhistamine response by ~80% at 3.0 mg/kg i.v.
Reached a mean plasma concentration of 25 ng/mL at 30 min post-dose at the ED50 dose (0.28 mg/kg i.v.).
Animal Model: (anesthetized)[1]
Dosage: 3 mg/kg (i.v., combined with loratadine); 10 mg/kg (p.o., combined with loratadine)
Administration: i.v.; single dose; 30 min prior to compound 48/80; p.o.; single dose; 2 h prior to compound 48/80
Result: Significantly blocked compound 48/80-induced increases in nasal resistance when administered intravenously at 3 mg/kg in combination with loratadine (3 mg/kg i.v.), with no effect on mean arterial blood pressure.
Significantly inhibited compound 48/80-induced decreases in nasal cavity volume when administered orally at 10 mg/kg in combination with loratadine (10 mg/kg p.o.), with no effect on systolic blood pressure.
Did not alter nasal responses to compound 48/80 when administered alone at either dose.
Molecular Weight

375.25

Formula

C18H16Cl2N4O

CAS No.
SMILES

O=C(NCC1=CC=C(CC2=CN=CN2)C=C1)NC3=CC(Cl)=CC(Cl)=C3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SCH 79687
Cat. No.:
HY-182296
Quantity:
MCE Japan Authorized Agent: